Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs¶
U.S. Food and Drug Administration. (2020). Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs: Guidance for Industry.
Cited by¶
2 citations across 2 artifacts.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Extrapolation Beyond Sampled Regime
- First, pharmacological dosing: the calibrated apparatus is a drug's efficacy-and-safety profile with its dosing guidance; the sampled regime is the clinical-trial cohort defined by inclusion criteria — typically adults of a certain age range, excluding pregnancy, paediatrics, severe comorbidity, and polypharmacy.
This sourceTreats trial eligibility (inclusion/exclusion) criteria as defining the studied population — typically excluding pregnancy, pediatrics, severe comorbidity, and polypharmacy — and warns that narrow criteria limit generalizability to the populations that will ultimately receive the drug.
- First, pharmacological dosing: the calibrated apparatus is a drug's efficacy-and-safety profile with its dosing guidance; the sampled regime is the clinical-trial cohort defined by inclusion criteria — typically adults of a certain age range, excluding pregnancy, paediatrics, severe comorbidity, and polypharmacy.
- Intersection
- and to clinical-trial eligibility (each inclusion criterion's cohort, the joint cohort, the empty case meaning "no enrollable patient").
This sourceDocuments that the eligible cohort is the intersection of inclusion/exclusion criteria and that overly restrictive criteria can leave too few or no enrollable patients.
- and to clinical-trial eligibility (each inclusion criterion's cohort, the joint cohort, the empty case meaning "no enrollable patient").
Verification¶
This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.
Links previously used in the corpus¶
Before the registry existed this work was also linked 1 other way.
Registry ID ref:f57971a908c4 · see in the full table